SIRT3 and metabolic dysfunction-associated steatotic liver disease: We previously found that SIRT3 could be upregulated by DHM treatment, and SIRT3 enrichment could promote mitochondrial respiratory capacity and maintenance of redox homeostasis in NAFLD [24, 47].